A new report from RFC Ambrian lays out the commanding position China has taken in the gallium market and the outlook for ...

By adopting FDA-endorsed endpoints that are easier to achieve, Dimerix has bolstered the chances of its pivotal kidney drug trial succeeding.

The ASX 200 closed nearly flat, down 1.2 points. Info tech's rally faltered, but the gold index climbed 1.09pc amid USD decline.

Robert Friedland's Sunrise Energy Metals has leveraged strong demand to lift a capital raise $7.5 million for its Syerston ...